ENO1 and gastric cancer: Combining the data shown in Supplementary Fig. 6b, our analysis of clinical gastric cancer samples from TCGA and RNA-Seq results consistently revealed that ENO1 influenced the levels of two key glycolytic products, ATP and lactate.